Sun Pharma Advanced Research Co Stock

Sun Pharma Advanced Research Co Forward P/E

The Forward P/E Ratio of Sun Pharma Advanced Research Co (SPARC.NS) as of Aug 19, 2026 is -11.39. In the previous year, Forward P/E Ratio was -10.07 — a change of 13.05% (lower).

Forward P/E

-11.39

YoY

13.05%

Last updated:

Forward P/E Ratio of Sun Pharma Advanced Research Co is 2026 -11.39 . Forward P/E Ratio of Sun Pharma Advanced Research Co was 2025 -10.07 . It decreases by 13.05% lower compared to the previous year.
Access this data via the Eulerpool API

Sun Pharma Advanced Research Co Stock analysis

What does Sun Pharma Advanced Research Co do? Sun Pharma Advanced Research Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sun Pharma Advanced Research Co stock

Forward P/E Ratio of Sun Pharma Advanced Research Co is -11.39 in 2026.

Forward P/E Ratio of Sun Pharma Advanced Research Co changed from -10.07 to -11.39, representing a 13.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Sun Pharma Advanced Research Co since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Sun Pharma Advanced Research Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Sun Pharma Advanced Research Co

All Key Metrics — Sun Pharma Advanced Research Co